6. Pittrof et al. claim that obstetricians may undertake more ultrasound surveillance of any pregnancy that has been exposed to a new drug with a 'black triangle' label from the Medicines and Healthcare products Regulatory Agency (intensively monitored drug). In such circumstances, a fetal anomaly scan would be the most appropriate form of obstetric monitoring and antenatal patients in the UK are currently offered a fetal anomaly scan (included in our cost analysis). Clearly however it is impossible to account for any additional tests that individual obstetricians may, or may not, institute in individual cases.
展开▼